Trade Amgen AMGN

Sell
 Buy

Amgen live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Amgen News

Emma Rose 2025 Nov 13, 00:00

Yen Weakness: Assessing the Risk of Japanese Intervention

Ava Grace 2025 Nov 13, 00:00

AI Investment Risks: Michael Burry & Jim Chanos Sound the Alarm on Tech Earnings

Liam James 2025 Nov 13, 00:00

Goldman CEO Issues Stark Warning on US Debt Sustainability

Noah Lee 2025 Nov 13, 00:00

Wells Fargo Strategists Raise S&P 500 Target, Citing Buy Signals and Market Catalysts

Liam James 2025 Nov 13, 00:00

Goldman Sachs Predicts US Stock Market Underperformance Over Next Decade

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Frances Wang 2025 Nov 11, 16:00

Stock market today: NASDAQ: NVDA slides, MSFT stock, AAPL jumps 2%

Frances Wang 2025 Nov 11, 16:00

XRP price prediction: Why Is XRP price rising today? Could XRP hit $10?

Latest news

Show more
Liam James 2025 Nov 13, 16:20

US Penny Production Halted: Is Bitcoin's Relevance Growing?

Emma Rose 2025 Nov 13, 15:30

Czech National Bank Tests Crypto Reserve with $1 Million Investment

Noah Lee 2025 Nov 13, 15:10

Acurast Raises $11M for Decentralized Confidential Computing on Smartphones

Liam James 2025 Nov 13, 14:10

OKX Enters US DEX Trading: A Look at the New Feature and Its Implications

Liam James 2025 Nov 13, 14:10

Circle Ventures into FX Market with Stablecoin Platform on Arc Blockchain

Sophia Claire 2025 Nov 13, 13:10

Arbitrum's DeFi Revival: An Analysis of the Arbitrum Foundation's Strategy

Sophia Claire 2025 Nov 13, 12:10

Warden Protocol: A Full-Stack Approach in the AI Agent Arena

Ava Grace 2025 Nov 13, 12:10

Metaplanet's Bitcoin Valuation Gains Plunge Amid Crypto Market Headwinds

Info

Spread

2.27

Spread (%)

0.6659 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

181080276992

Shares Outstanding

538480671

Earnings Date (Next)

1999-11-22

Div Yield

2025-12-12

Ex-Dividend Date

2025-11-21

Forward annual dividend rate

9.52

Forward annual dividend yield

0.0283

EPS

12.95

Learn more about this instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 12, 16:00

WTI crude oil price today: WTI crude oil target, trade oil with markets.com

Ghko B 2025 Nov 11, 16:00

Crude oil trading: commodity trading, best way to invest in WTI/Brent oil?

Ghko B 2025 Nov 11, 16:00

WTI trades at $60.75: WTI oil up 1.7%, What influences WTI oil prices?

Trustpilot